230 related articles for article (PubMed ID: 7324079)
41. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
[TBL] [Abstract][Full Text] [Related]
42. Autoimmune factors in African cirrhosis. Correlation with hepatitis B surface antigen and antibody.
Sadikali F; Doniach D
Am J Gastroenterol; 1975 Dec; 64(6):484-9. PubMed ID: 1083141
[TBL] [Abstract][Full Text] [Related]
43. Effect of uniplant on liver function in Egyptian women with asymptomatic hepatitis B virus infection.
Shaamsh AH; Salem HT; Shaaban MM; Ghaneima SA; Helal SR
Afr J Reprod Health; 2005 Apr; 9(1):24-31. PubMed ID: 16104652
[TBL] [Abstract][Full Text] [Related]
44. Hepatitis B core antigen in liver tissue from HBs-positive, HBe-negative patients.
Karpinska E; Wawrzynowicz-Syczewska M; Chosia M; Jurczyk K; Urbanowicz W; Boron-Kaczmarska A
Hepatogastroenterology; 2004; 51(57):709-12. PubMed ID: 15143898
[TBL] [Abstract][Full Text] [Related]
45. Genotype B hepatitis B virus is associated with severe icteric flare-up of chronic hepatitis B virus infection in Hong Kong.
Chan HL; Tsang SW; Wong ML; Tse CH; Leung NW; Chan FK; Sung JJ
Am J Gastroenterol; 2002 Oct; 97(10):2629-33. PubMed ID: 12385451
[TBL] [Abstract][Full Text] [Related]
46. [Immunohistochemical study of hepatitis B and D virus antigens (HBsAg, HBcAg, HDAg) in chronic liver diseases].
Horváth G; Stotz G; Schaff Z; Tolvaj G; Dávid K
Orv Hetil; 1996 May; 137(21):1133-8. PubMed ID: 8757107
[TBL] [Abstract][Full Text] [Related]
47. Inapparent "wild-type" and "e-minus variant" HBV infection in patients with HCV-related chronic hepatitis.
Sardo MA; Rodinò G; Brancatelli S; Pernice M; Campo S; Squadrito G; Russo F; Raimondo G
Liver; 1994 Oct; 14(5):241-4. PubMed ID: 7997082
[TBL] [Abstract][Full Text] [Related]
48. Analysis of hepatitis B virus in the cerumen and otorrhea of chronic HBV-infected patients: is there a hepatitis B virus infectivity?
Goh EK; Son BH; Kong SK; Chon KM; Cho KS
Otol Neurotol; 2008 Oct; 29(7):929-32. PubMed ID: 18665006
[TBL] [Abstract][Full Text] [Related]
49. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection.
Manesis EK; Papatheodoridis GV; Sevastianos V; Cholongitas E; Papaioannou C; Hadziyannis SJ
Am J Gastroenterol; 2003 Oct; 98(10):2261-7. PubMed ID: 14572577
[TBL] [Abstract][Full Text] [Related]
50. Prognosis of hepatitis B virus surface antigen carriers in relation to routine liver function tests: a prospective study.
Sakuma K; Takahara T; Okuda K; Tsuda F; Mayumi M
Gastroenterology; 1982 Jul; 83(1 Pt 1):114-7. PubMed ID: 7075936
[TBL] [Abstract][Full Text] [Related]
51. Hepatic pathologic condition in asymptomatic Australia antigen carriers. A light microscopical study of 26 cases and a review of the literature.
Shrago SS; Auslander MO; Gitnick GL
Arch Pathol Lab Med; 1977 Dec; 101(12):648-51. PubMed ID: 579306
[TBL] [Abstract][Full Text] [Related]
52. Nonparenteral transmission of viral hepatitis in Greece.
Hadziyannis SJ
Am J Med Sci; 1975; 270(2):313-8. PubMed ID: 1235473
[TBL] [Abstract][Full Text] [Related]
53. A histological and serological study of persistent hepatitis B antigenaemia.
Pinn TG; Woodfield DG
N Z Med J; 1983 Mar; 96(727):153-6. PubMed ID: 6572313
[TBL] [Abstract][Full Text] [Related]
54. Studies of clinically latent cirrhosis.
Kobayashi K; Inagaki Y; Unoura M; Tanaka N; Kato Y; Hattori N
Hepatogastroenterology; 1990 Dec; 37 Suppl 2():77-80. PubMed ID: 1964671
[TBL] [Abstract][Full Text] [Related]
55. Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and in recurrent infection.
Ranki M; Schätzl HM; Zachoval R; Uusi-Oukari M; Lehtovaara P
Hepatology; 1995 Jun; 21(6):1492-9. PubMed ID: 7768492
[TBL] [Abstract][Full Text] [Related]
56. Clinico-pathological studies of the liver in asymptomatic carriers of Australia antigen.
Ichida F; Sasaki H; Sekine T; Inagaki T
Acta Hepatogastroenterol (Stuttg); 1975 Feb; 22(1):13-21. PubMed ID: 1119298
[TBL] [Abstract][Full Text] [Related]
57. Development of antibody to hepatitis B surface antigen after liver transplantation for chronic hepatitis B.
Lo CM; Fung JT; Lau GK; Liu CL; Cheung ST; Lai CL; Fan ST; Wong J
Hepatology; 2003 Jan; 37(1):36-43. PubMed ID: 12500186
[TBL] [Abstract][Full Text] [Related]
58. Liver function and hepatitis markers in carriers of hepatitis B virus in New Zealand.
Hopkirk N; Moyes CD; Lucas CR
N Z Med J; 2000 Apr; 113(1107):114-6. PubMed ID: 10834277
[TBL] [Abstract][Full Text] [Related]
59. Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection.
Cacciola I; Pollicino T; Squadrito G; Cerenzia G; Villari D; de Franchis R; Santantonio T; Brancatelli S; Colucci G; Raimondo G
Hepatology; 2000 Feb; 31(2):507-12. PubMed ID: 10655278
[TBL] [Abstract][Full Text] [Related]
60. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis.
Sagnelli E; Coppola N; Scolastico C; Filippini P; Santantonio T; Stroffolini T; Piccinino F
Hepatology; 2000 Nov; 32(5):1106-10. PubMed ID: 11050062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
